Dabrafenib, Trametinib Active in Pediatric Glioma With BRAF V600
More responses, longer progression-free survival seen compared with standard chemo for low-grade glioma with BRAF V600 mutations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.